Literature DB >> 23269440

Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.

James J P Alix, Daniel J Blackburn, Dilraj Sokhi, Ian Craven, Basil Sharrack, John A Snowden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23269440     DOI： 10.1007/s00415-012-6796-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.

Authors:  James T Reston; Stacey Uhl; Jonathan R Treadwell; Richard A Nash; Karen Schoelles
Journal:  Mult Scler       Date:  2010-10-04       Impact factor: 6.312

Review 2.  Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis.

Authors:  E Capello; G L Mancardi
Journal:  Neurol Sci       Date:  2004-11       Impact factor: 3.307

3.  Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis.

Authors:  Giovanni Luigi Mancardi; Alessandra Murialdo; Paolo Rossi; Francesca Gualandi; Gianvito Martino; Alberto Marmont; Fabio Ciceri; Angelo Schenone; Roberto Carlo Parodi; Elisabetta Capello; Giancarlo Comi; Antonio Uccelli
Journal:  Mult Scler       Date:  2005-06       Impact factor: 6.312

4.  Autologous hematopoietic stem cell transplantation for multiple sclerosis--if confused or hesitant, remember: 'treat with standard immune suppressive drugs and if no inflammation, no response'.

Authors:  Richard K Burt; Roumen Balabanov; Julio Voltarelli; Amilton Barreira; Joachim Burman
Journal:  Mult Scler       Date:  2012-06       Impact factor: 6.312

5.  Cyclophosphamide therapy for MS.

Authors:  S A Gauthier; H L Weiner
Journal:  Int MS J       Date:  2005-08

6.  Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.

Authors:  J Fagius; J Lundgren; G Oberg
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

7.  No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.

Authors:  R Le Bouc; H Zéphir; B Majed; A Vérier; M Marcel; P Vermersch
Journal:  Mult Scler       Date:  2011-08-15       Impact factor: 6.312

8.  Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

Authors:  Richard K Burt; Yvonne Loh; Bruce Cohen; Dusan Stefoski; Dusan Stefosky; Roumen Balabanov; George Katsamakis; Yu Oyama; Eric J Russell; Jessica Stern; Paolo Muraro; John Rose; Alessandro Testori; Jurate Bucha; Borko Jovanovic; Francesca Milanetti; Jan Storek; Julio C Voltarelli; William H Burns
Journal:  Lancet Neurol       Date:  2009-01-29       Impact factor: 44.182

9.  A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.

Authors:  R Saccardi; M S Freedman; M P Sormani; H Atkins; D Farge; L M Griffith; G Kraft; G L Mancardi; R Nash; M Pasquini; R Martin; P A Muraro
Journal:  Mult Scler       Date:  2012-03-01       Impact factor: 6.312

10.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483
  10 in total
  5 in total

Review 1.  The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.

Authors:  Rokhsareh Meamar; Shahrzad Nematollahi; Leila Dehghani; Omid Mirmosayyeb; Vahid Shayegannejad; Keivan Basiri; Amir Pouya Tanhaei
Journal:  Adv Biomed Res       Date:  2016-03-16

Review 2.  Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience.

Authors:  Daniela Currò; Gianluigi Mancardi
Journal:  Neurol Sci       Date:  2016-04-12       Impact factor: 3.307

Review 3.  Cell Therapy for Multiple Sclerosis.

Authors:  Pamela Sarkar; Claire M Rice; Neil J Scolding
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 6.497

Review 4.  Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?

Authors:  Maha M Bakhuraysah; Christopher Siatskas; Steven Petratos
Journal:  Stem Cell Res Ther       Date:  2016-01-16       Impact factor: 6.832

Review 5.  Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis.

Authors:  Thomas Low Tat Kuan; Farahnaz Amini; Marjan Sadat Seghayat
Journal:  Iran J Basic Med Sci       Date:  2017-07       Impact factor: 2.699
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.